Evidence map›Paper›PMID 34469807›Full record

ReviewComputer methods and programs in biomedicine2021

An Accelerated Life Model Analog for Discrete Survival and Count Data.

Alan D Hutson

Abstract readReview
In one paragraph

Review in Computer methods and programs in biomedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Alan D HutsonRoswell Park Cancer Institute, Department of Biostatistics and Bioinformatics, Elm and Carlton Streets, Buffalo, NY 14623, United States. Electronic address: alan.hutson@roswellpark.org.

Funding

Statistics CoreU10CA180822 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Mei-Yin C Polley · 2014 to 2026
$146.4M
Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCIU24CA232979 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI HUTSON, ALAN DAVID, LIU, SONG · 2018 to 2024
$8.9M
YAP1 and RB1 cooperate to regulate lung cancer lineage plasticity and therapeutic resistanceU24CA274159 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI DAVID W. GOODRICH, Alan David Hutson · 2022 to 2026
$8.5M
NCI NIH HHS P30 CA016056NCI NIH HHS U10 CA180822NCI NIH HHS U24 CA232979NCI NIH HHS U24 CA274159
6 · The paper itself

Abstract

BACKGROUND AND

objectiveOur goal is to provide an overall strategy for utilizing continuous accelerated life models in the discrete setting that provides a unique and flexible modeling approach across a variety of hazard shapes.

methodsWe convert well-known continuous accelerated life distributions into their discrete counterpart and show theoretically that the existing software that currently exists to accommodate, left, right and interval censoring in the continuous case is re-usable in the discrete setting due to the structure of the likelihood equations.

resultsWe demonstrate across a variety of simulated and real-world data that our modeling approach can accommodate discrete data that may either be approximately symmetric, left-skewed or right skewed, overcoming the limitations of more traditional modeling approaches.

conclusionsWe illustrate both theoretically and through simulations that our approach for accommodating discrete failure time and count data is quite flexible. We demonstrate that the special case of the discrete Weibull model readily can accommodate truly Poisson distributed data and has a great degree of flexibility for non-Poisson distributed data.

Indexed as

Models, StatisticalSoftwareSurvival Analysisfailure-timelog-logistic distributionlog-normal distributionnegative binomial distributionPoisson distributionproportional-oddsWeibull distribution

Identifiers

PMID34469807
PMCPMC8478857

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.